Based on this observation, we speculated that BCR-ABL and its relevant pathways might be falsely over-connected with NPM1. Additional cellular growth and proliferation pathways may in turn be activated through the mediation of NPM1 in CML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.